Logo

FTC Clears Danaher's Proposed Acquisition of Beckman Coulter

Mar 10, 2011

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The US Federal Trade Commission has granted early termination of the review period for Danaher's proposed $6.8 billion acquisition of Beckman Coulter, according to a notice posted on the agency's website today.

The firms had announced the deal in early February, and at the time said they expected to complete the transaction in the first half of 2011.

Beckman recently reported that its fiscal-year 2010 revenues increased 12 percent to $3.66 billion. Its operations would be added to Danaher's Life Sciences & Diagnostics division, which posted 2010 revenues of $2.3 billion.

Filed under

Beckman Coulter
Danaher
FTC clearance
mergers & acquisitions
FTC
Breaking News
The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.